Device brand name · Steerable guide catheter
Mitraclip System Steerable Guide Catheter: medical device reports filed with FDA
1,528 reports name it, 2013–2026. Manufacturer given most often on reports: Av-Temecula-Ct. Product code DRA.
- 1,528
- device reports naming the brand
- 0% of all MAUDE reports · about 121 a year
- 16
- reports, 12 months to August 2026
- 13 in the 12 months before
- 43%
- classified as malfunction
- 61.9% across the product code
- 3%
- classified as death, as reported
- 46 reports · not verified by FDA
1,528 medical device reports received by FDA name the brand "Mitraclip System Steerable Guide Catheter" (steerable guide catheter); the manufacturer given most often on reports is Av-Temecula-Ct; received from November 2013 to June 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
16 reports arrived in the 12 months to August 2026, up 23% from 13 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (54%), malfunction (43%) and death (3%); across all catheter, steerable reports (product code DRA) death is recorded in 1.8% and malfunction in 61.9%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are leak/splash (24%), break (7.9%) and torn material (6.9%). The patient problems coded most often are no patient involvement, atrial perforation and thrombosis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 13,946 reports carrying product code DRA. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Leak/splashthe device leaked | 367 | 24% | 16.7% |
| Breakthe device broke | 121 | 7.9% | 1.8% |
| Torn material | 105 | 6.9% | 0.8% |
| Mechanical problema mechanical problem | 82 | 5.4% | 0.9% |
| Device operates differently than expectedthe device behaved unexpectedly | 60 | 3.9% | 0.8% |
| Improper or incorrect procedure or method | 56 | 3.7% | 0.9% |
| Difficult to removethe device was hard to remove | 55 | 3.6% | 1.1% |
| Difficult to insertthe device was hard to insert | 45 | 2.9% | 1.3% |
| Failure to advance | 45 | 2.9% | 1.1% |
| Unstable | 33 | 2.2% | 0.4% |
| Positioning failure | 30 | 2% | 0.9% |
| Deformation due to compressive stress | 29 | 1.9% | 1.4% |
| Unintended movement | 29 | 1.9% | 0.8% |
| Loose or intermittent connection | 26 | 1.7% | 0.2% |
| Physical resistance | 25 | 1.6% | 0.2% |
| Detachment of device component | 21 | 1.4% | 0.5% |
| Difficult or delayed positioning | 18 | 1.2% | 0.5% |
| Material split, cut or torn | 17 | 1.1% | 0.7% |
| Difficult to position | 16 | 1% | 0.2% |
| Noise, audible | 11 | 0.7% | 0.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 275 | 18% |
| Atrial perforation | 274 | 17.9% |
| Thrombosis | 129 | 8.4% |
| Perforation | 105 | 6.9% |
| Hemorrhage/blood loss/bleeding | 95 | 6.2% |
| Low blood pressure/ hypotension | 81 | 5.3% |
| Pericardial effusionfluid around the heart | 50 | 3.3% |
| Air embolism | 35 | 2.3% |
| Tissue damage | 29 | 1.9% |
| Cardiac arrestthe heart stopped | 26 | 1.7% |
| Hematomaa collection of blood under the skin or in tissue | 25 | 1.6% |
| Deaththe patient died; cause not stated by this term | 24 | 1.6% |
| Heart failure | 16 | 1% |
| Cardiac tamponade | 12 | 0.8% |
| Fistula | 12 | 0.8% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Mitraclip System Steerable Guide Catheter | Product code DRA | All MAUDE reports |
|---|---|---|---|
| Reports | 1,528 | 13,946 | 26,136,888 |
| Share of that pool | — | 11% | 0% |
| Classified as death, per 1,000 reports | 30 | 18 | 9 |
| Classified as injury | 54% | 36.2% | 36.2% |
| Classified as malfunction | 43% | 61.9% | 62.3% |
| Filed by the manufacturer | 100% | 99.3% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DRA
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| FARADRIVE Steerable Sheath Clear | 4,154 | 1,559 | 0.5% |
| FlexCath Advance Steerable Sheath | 2,941 | 58 | 3.5% |
| G4 Steerable Guiding Catheter | 896 | 0 | 1.6% |
| FlexCath Contour Steerable Sheath | 871 | 399 | 1.5% |
| Faradrive | 792 | 192 | 0.9% |
| Mitraclip | 3,357 | 1,161 | 2% |
| Polarsheath | 418 | 12 | 1.2% |
| Flexcath Steerable Sheath | 365 | 0 | 0.3% |
| Steerable Guide Catheter | 336 | 33 | 1.2% |
| G4 Steerable Guiding Catheter Ce | 262 | 2 | 1.1% |
| FARADRIVE Steerable Sheath | 192 | 102 | 4.2% |
| Mitraclip G4 Steerable Guide Catheter Mdr | 191 | 0 | 1.6% |
| Heartlight | 206 | 0 | 1% |
| Artisan? | 934 | 127 | 0.6% |
| Arctic Front Advance Cardiac Cryoablation Catheter | 2,364 | 46 | 2.6% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Mitraclip System Steerable Guide Catheter reports
How many FDA reports name Mitraclip System Steerable Guide Catheter?
1,528 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 16 in the latest 12 months.
What kinds of events are reported?
injury (54%), malfunction (43%) and death (3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
leak/splash (24%), break (7.9%), torn material (6.9%), mechanical problem (5.4%) and device operates differently than expected (3.9%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Mitraclip System Steerable Guide Catheter was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.